Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Monopar Therapeutics Inc. Closes $19.2 Million Public Offering of Common Stock
Oct 30, 2024•over 1 year ago
Contract Type
contract
NorthbrookBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
Monopar Therapeutics Inc. announced the closing of a best efforts public offering of shares of its common stock at a public offering price of $16.25 per share, resulting in aggregate gross proceeds of approximately $19.2 million. The net proceeds from the offering will be used for general corporate purposes, including research and development expenditures, clinical trial expenditures, manufacture and supply of product, and working capital.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months